JP2017184729A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017184729A5 JP2017184729A5 JP2017046859A JP2017046859A JP2017184729A5 JP 2017184729 A5 JP2017184729 A5 JP 2017184729A5 JP 2017046859 A JP2017046859 A JP 2017046859A JP 2017046859 A JP2017046859 A JP 2017046859A JP 2017184729 A5 JP2017184729 A5 JP 2017184729A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- pde4d7
- prostate cancer
- sample
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159960.5 | 2009-05-12 | ||
| EP09159960 | 2009-05-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510424A Division JP6148007B2 (ja) | 2009-05-12 | 2010-05-11 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018205900A Division JP2019059733A (ja) | 2009-05-12 | 2018-10-31 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017184729A JP2017184729A (ja) | 2017-10-12 |
| JP2017184729A5 true JP2017184729A5 (enExample) | 2018-02-08 |
| JP6430560B2 JP6430560B2 (ja) | 2018-11-28 |
Family
ID=40843709
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510424A Active JP6148007B2 (ja) | 2009-05-12 | 2010-05-11 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
| JP2015188247A Active JP6105012B2 (ja) | 2009-05-12 | 2015-09-25 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
| JP2017046859A Active JP6430560B2 (ja) | 2009-05-12 | 2017-03-13 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
| JP2018205900A Pending JP2019059733A (ja) | 2009-05-12 | 2018-10-31 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510424A Active JP6148007B2 (ja) | 2009-05-12 | 2010-05-11 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
| JP2015188247A Active JP6105012B2 (ja) | 2009-05-12 | 2015-09-25 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018205900A Pending JP2019059733A (ja) | 2009-05-12 | 2018-10-31 | 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8753892B2 (enExample) |
| EP (2) | EP2430191B1 (enExample) |
| JP (4) | JP6148007B2 (enExample) |
| KR (1) | KR101778036B1 (enExample) |
| CN (2) | CN102549167B (enExample) |
| BR (1) | BRPI1007093A2 (enExample) |
| DK (1) | DK2430191T3 (enExample) |
| ES (1) | ES2700877T3 (enExample) |
| RU (1) | RU2651474C2 (enExample) |
| WO (1) | WO2010131195A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3343647B2 (ja) | 1997-07-22 | 2002-11-11 | 株式会社岡田建築デザインルーム | 木造軸組在来構法による既存建物を、外部より鋼製受け梁と鋼製筋かいフレームにより耐震補強をなす架構 |
| BRPI1007704A2 (pt) * | 2009-05-12 | 2019-12-03 | Koninklijke Philips Electronics N.V. | fosfodiesterase 4d7 (pde4d7), para uso como um marcador para câncer de próstata maligno, sensível a hormônio; composição ou método de aquisição de dados ou imunoensaio para diagnosticar, detectar, monitorar ou prognosticar câncer de prostata maligno, sensível ao hormônio ou para diagnosticar, detectar, monitorar ou prognosticar a progressão para câncer de próstata maligno, sensível a hormônio; uso de pde4d7; imunoensaio para discriminar entre um tumor de próstata benigno e um câncer de próstata maligno, sensível a hormônio; método para identificar um indivíduo para elegibilidade para terapia contra câncer de próstata maligno, sensível a hormônio; imunoensaio para classificar um indivíduo ou corte de indivíduos com uma doença de câncer de próstata maligno, sensível a hormônio; composição farmacêutica inibitória para o tratamento ou prevenção de câncer de próstata maligno, sensível a hormônio; composição farmacêutica estimulatória; e; uso de um anticorpo específico para a proteína pde4d7 e/ou uma variante de anticorpo específica para a proteína pde4d7 |
| CN102549167B (zh) * | 2009-05-12 | 2017-04-26 | 皇家飞利浦电子股份有限公司 | 作为前列腺癌标志物的磷酸二酯酶4d7 |
| JP6096109B2 (ja) | 2010-04-13 | 2017-03-15 | ジーエーエヌ システムズ インコーポレイテッド | アイランドトポロジを用いる高密度窒化ガリウム装置 |
| GB201322034D0 (en) | 2013-12-12 | 2014-01-29 | Almac Diagnostics Ltd | Prostate cancer classification |
| GB201504763D0 (en) | 2015-03-20 | 2015-05-06 | Mironid Ltd | Compounds and uses |
| DK3303616T3 (da) | 2015-05-29 | 2021-03-01 | Koninklijke Philips Nv | Fremgangsmåder til prognose af prostatakræft |
| CN105893782A (zh) * | 2016-05-26 | 2016-08-24 | 江苏省人民医院 | 前列腺癌风险预测装置 |
| GB201616439D0 (en) | 2016-09-28 | 2016-11-09 | Mironid Limited | Compounds and uses |
| CN106544430A (zh) * | 2016-11-04 | 2017-03-29 | 叶伟亮 | 一种检测前列腺癌的分子标记物及其应用 |
| WO2018099884A1 (en) | 2016-12-01 | 2018-06-07 | Koninklijke Philips N.V. | Risk scores based on human phosphodiesterase 4d variant 7 expression |
| EP3450981A1 (en) * | 2017-08-28 | 2019-03-06 | Trizell GmbH | Btnl8 as a marker for tregs |
| CN111511930B (zh) | 2017-11-03 | 2024-11-22 | 牛津生物动力有限责任公司 | 通过染色体相互作用遗传调节免疫响应 |
| DE102017125780B3 (de) * | 2017-11-05 | 2018-12-13 | Dimo Dietrich | Verfahren zur Bestimmung des Ansprechens einer malignen Erkrankung auf eine Immuntherapie |
| KR102080887B1 (ko) * | 2017-11-07 | 2020-02-24 | 고려대학교 산학협력단 | Gcc2 유전자 또는 단백질을 과발현하는 엑소좀 기반 폐암 진단 또는 예후 예측용 마커 조성물 |
| WO2019158825A1 (en) * | 2018-02-16 | 2019-08-22 | Tampereen Korkeakoulusäätiö SR | Xrcc5 as biomarker for prostate cancer |
| GB201805527D0 (en) | 2018-04-04 | 2018-05-16 | Mironid Ltd | Compounds and their use as pde4 activators |
| KR20220008175A (ko) * | 2020-07-13 | 2022-01-20 | 가톨릭대학교 산학협력단 | 전립선암 환자의 예후 진단 및 치료 전략 결정용 병리등급 특이적 마커 |
| EP3960876A1 (en) * | 2020-08-31 | 2022-03-02 | Koninklijke Philips N.V. | Prediction of a response of a prostate cancer subject to radiotherapy based on pde4d7 correlated genes |
| CN112779348B (zh) * | 2020-12-31 | 2022-05-20 | 四川农业大学 | 一种小麦单位面积穗数主效qtl位点及紧密连锁的kasp引物和应用 |
| EP4360711A1 (en) * | 2022-10-27 | 2024-05-01 | Koninklijke Philips N.V. | Treatment of prostate cancer by promoting pde4d7 |
| EP4608430A1 (en) | 2022-10-27 | 2025-09-03 | Koninklijke Philips N.V. | Treatment of prostate cancer by promoting pde4d7 |
| EP4600377A1 (en) | 2024-02-12 | 2025-08-13 | Koninklijke Philips N.V. | Prediction of an outcome of a subject suffering from a glioma |
| EP4747407A1 (en) | 2023-07-18 | 2026-05-27 | Koninklijke Philips N.V. | Prediction of an outcome of a subject suffering from a glioma |
| EP4620461A1 (en) | 2024-03-22 | 2025-09-24 | Koninklijke Philips N.V. | Treatment of prostate cancer by inhibiting short pde4d isoforms |
| EP4722388A1 (en) | 2024-10-03 | 2026-04-08 | Koninklijke Philips N.V. | Prediction of an outcome of a subject suffering from acute myoloid leukemia |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932465A (en) * | 1997-10-16 | 1999-08-03 | Icos Corporation | Phosphodiesterase 8A |
| US20090176722A9 (en) | 2000-01-28 | 2009-07-09 | Shiv Srivastava | Androgen-regulated PMEPA1 gene and polypeptides |
| WO2002060875A1 (en) * | 2001-01-31 | 2002-08-08 | Pfizer Products Inc. | Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| IS7221A (is) * | 2001-11-15 | 2004-04-15 | Memory Pharmaceuticals Corporation | Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra |
| US20030220273A1 (en) | 2002-05-15 | 2003-11-27 | Isis Pharmaceuticals Inc. | Antisense modulation of phosphodiesterase 4D expression |
| WO2004042389A2 (en) * | 2002-11-08 | 2004-05-21 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) |
| AU2003283303A1 (en) | 2002-11-08 | 2004-06-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
| EP1426767A1 (en) | 2002-12-04 | 2004-06-09 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (PDE4C) |
| CA2458085A1 (en) * | 2003-03-21 | 2004-09-21 | F. Hoffmann-La Roche Ag | Transcriptional activity assay |
| WO2004090157A1 (en) * | 2003-04-10 | 2004-10-21 | F. Hoffmann-La Roche Ag | The use of pde4d in the screening for medicaments against atherosclerosis |
| US7250416B2 (en) * | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
| CA2652539A1 (en) * | 2006-05-19 | 2007-11-29 | Topigen Pharmaceuticals Inc. | Oligonucleotides affecting expression of phosphodiesterases |
| EP2044215B1 (en) | 2006-07-21 | 2015-03-25 | Epigenomics AG | Methods for analyses of cellular proliferative disorders of the prostate |
| AU2007324128B2 (en) | 2006-10-10 | 2013-10-10 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
| AU2008328222A1 (en) * | 2007-11-23 | 2009-05-28 | Epigenomics Ag | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
| CN102549167B (zh) * | 2009-05-12 | 2017-04-26 | 皇家飞利浦电子股份有限公司 | 作为前列腺癌标志物的磷酸二酯酶4d7 |
| BRPI1007704A2 (pt) * | 2009-05-12 | 2019-12-03 | Koninklijke Philips Electronics N.V. | fosfodiesterase 4d7 (pde4d7), para uso como um marcador para câncer de próstata maligno, sensível a hormônio; composição ou método de aquisição de dados ou imunoensaio para diagnosticar, detectar, monitorar ou prognosticar câncer de prostata maligno, sensível ao hormônio ou para diagnosticar, detectar, monitorar ou prognosticar a progressão para câncer de próstata maligno, sensível a hormônio; uso de pde4d7; imunoensaio para discriminar entre um tumor de próstata benigno e um câncer de próstata maligno, sensível a hormônio; método para identificar um indivíduo para elegibilidade para terapia contra câncer de próstata maligno, sensível a hormônio; imunoensaio para classificar um indivíduo ou corte de indivíduos com uma doença de câncer de próstata maligno, sensível a hormônio; composição farmacêutica inibitória para o tratamento ou prevenção de câncer de próstata maligno, sensível a hormônio; composição farmacêutica estimulatória; e; uso de um anticorpo específico para a proteína pde4d7 e/ou uma variante de anticorpo específica para a proteína pde4d7 |
| ES2711364T3 (es) * | 2013-03-15 | 2019-05-03 | Iris Int Inc | Sistemas y métodos de célula de flujo para el análisis de partículas en muestras de sangre |
-
2010
- 2010-05-11 CN CN201080033823.4A patent/CN102549167B/zh active Active
- 2010-05-11 WO PCT/IB2010/052073 patent/WO2010131195A1/en not_active Ceased
- 2010-05-11 KR KR1020117029715A patent/KR101778036B1/ko not_active Expired - Fee Related
- 2010-05-11 US US13/320,283 patent/US8753892B2/en active Active
- 2010-05-11 BR BRPI1007093A patent/BRPI1007093A2/pt not_active Application Discontinuation
- 2010-05-11 RU RU2011150279A patent/RU2651474C2/ru active
- 2010-05-11 EP EP10726251.1A patent/EP2430191B1/en active Active
- 2010-05-11 DK DK10726251.1T patent/DK2430191T3/en active
- 2010-05-11 JP JP2012510424A patent/JP6148007B2/ja active Active
- 2010-05-11 EP EP18187420.7A patent/EP3434787B1/en active Active
- 2010-05-11 CN CN201710192366.7A patent/CN107267482A/zh active Pending
- 2010-05-11 ES ES10726251T patent/ES2700877T3/es active Active
-
2015
- 2015-09-25 JP JP2015188247A patent/JP6105012B2/ja active Active
-
2017
- 2017-03-13 JP JP2017046859A patent/JP6430560B2/ja active Active
-
2018
- 2018-10-31 JP JP2018205900A patent/JP2019059733A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6630766B2 (ja) | 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法 | |
| JP2012526544A5 (enExample) | ||
| US10408839B2 (en) | Biomarker panel for diagnosing cancer | |
| RU2016134839A (ru) | Биомаркер и способы для ранней диагностики болезни альцгеймера | |
| WO2012129325A1 (en) | Molecular analysis of tumor samples | |
| JP6983221B2 (ja) | 大腸癌の併用検査 | |
| US20210310080A1 (en) | Composition for diagnosing cancer using potassium channel proteins | |
| JP6415546B2 (ja) | 脳卒中の鑑別診断を支援する方法 | |
| US20160003786A1 (en) | Methods Of Detecting Cancer | |
| Xu et al. | Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma | |
| AU2012343537B2 (en) | Biomarker-based methods and biochips for aiding the diagnosis of stroke | |
| JP2012526543A5 (enExample) | ||
| JP7237587B2 (ja) | マーカー、ヒト精巣上体タンパク質４（ｈｅ４）に基づく肺腺癌の再発を検出する方法および関連する使用 | |
| JP6917628B2 (ja) | 膵がん及び膵管内乳頭粘液性腫瘍のマーカー | |
| JP6361943B2 (ja) | 補体因子ｂタンパク質に特異的に結合する抗体及び糖鎖抗原１９−９タンパク質に特異的に結合する抗体を含む膵臓癌診断用キット | |
| EP3428648B1 (en) | Method for assisting prediction of recurrence risk in hepatocellular carcinoma patient, and use of a kit | |
| EP3215851B1 (en) | Lung cancer sub-typing method | |
| JP7046394B2 (ja) | グリオーマ検出用バイオマーカー | |
| WO2016143805A1 (ja) | 膀胱がんの検出方法 | |
| la Brzobohatá et al. | BIOM-37. EV-TRACK: EXTRACELLULAR VESICLE PROFILING FOR NON-INVASIVE GLIOBLASTOMA DIAGNOSIS AND MONITORING | |
| AU2018100578A4 (en) | Method for detection & diagnosis of oral cancer in a sample | |
| JP7126668B2 (ja) | 膠原病判定方法 | |
| WO2021245413A1 (en) | Methods of determining cancer | |
| JP2017215151A (ja) | 腎細胞癌マーカー及びその使用 |